Isosorbide mononitrate indications and usage: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Isosorbide dinitrate}} {{CMG}}; {{AE}} {{PB}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ISOSORBIDE MONONITRATE TABLET [ZYDUS ...")
 
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Isosorbide dinitrate}}
{{Isosorbide mononitrate
}}
{{CMG}}; {{AE}} {{PB}}
{{CMG}}; {{AE}} {{PB}}



Revision as of 19:23, 30 January 2014

Isosorbide mononitrate
ISOSORBIDE MONONITRATE tablet® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Description
Clinical Pharmacology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]



[1]

References

  1. "ISOSORBIDE MONONITRATE TABLET [ZYDUS PHARMACEUTICALS (USA) INC.]". Retrieved 30 January 2014.